September 3, 2024 – Page 8

Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September

Written by Customer Service on September 3, 2024. Posted in Public Companies.

HANOVER, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) announces that management will be participating in the following investor and industry conferences during the month of September: H.C. Wainwright 26th Annual Global Investment Conference, September 9-11, 2024, at the Lotte New York Palace Hotel. Management will be holding one-on-one meetings with investors and will deliver a company presentation. The recorded presentation will be available on demand beginning Monday, September 9th at 7:00am Eastern time on the Investors section of Processa’s website and here. European Society for Medical Oncology (ESMO) Congress 2024, September 13-17, 2024, in Barcelona. Management will be holding meetings with clinicians, researchers, industry key opinion leaders and potential partners. About Processa Pharmaceuticals,...

LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Written by Customer Service on September 3, 2024. Posted in Public Companies.

UTRECHT, The Netherlands and PHILADELPHIA, Sept. 03, 2024 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA”), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody® platform of bispecific gamma delta T cell engagers, today announced that Stephen Hurly, Chief Executive Officer of LAVA Therapeutics, will present at the H.C. Wainwright 26th Annual Global Investment Conference. Presentation DetailsFormat: Fireside ChatDate: Monday, September 9, 2024Time: 3:30 PM ET A webcast of the presentation can be accessed under the “Events” tab on the investor relations section of the LAVA Therapeutics website at https://ir.lavatherapeutics.com/news-events/events. The replay will be archived for 90 days following the presentation date. About LAVA Therapeutics LAVA Therapeutics N.V. is...

4DMT to Participate in the 2024 Cantor Global Healthcare Conference

Written by Customer Service on September 3, 2024. Posted in Public Companies.

EMERYVILLE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, today announced that management will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference. Members of the management team will also be available for one-on-one meetings. 2024 Cantor Global Healthcare Conference Presentation Date: Thursday, September 19, 2024 Presentation Time: 8:35 a.m. ET Webcast Link: Webcast An archived copy of the webcast will be available for up to one year by visiting the “Investors” section of the 4DMT website at https://ir.4dmoleculartherapeutics.com/events. About 4DMT 4DMT is a leading clinical-stage genetic medicines...

The Chefs’ Warehouse, Inc. to Participate in CL King’s 22nd Best Ideas Conference

Written by Customer Service on September 3, 2024. Posted in Public Companies.

RIDGEFIELD, Conn., Sept. 03, 2024 (GLOBE NEWSWIRE) — The Chefs’ Warehouse, Inc. (the “Company”) (Nasdaq: CHEF), a premier distributor of specialty food products in the United States, the Middle East and Canada, today announced that the Company will participate in a virtual fireside chat at CL King’s 22nd Best Ideas Conference on Monday, September 16, 2024. The fireside chat will begin at 8:45 a.m. ET. Investors and interested parties may listen to a webcast of the fireside chat by visiting the Company’s investor relations website at http://investors.chefswarehouse.com/. About The Chefs’ Warehouse The Chefs’ Warehouse, Inc. (http://www.chefswarehouse.com) is a premier distributor of specialty food products in the United States, the Middle East and Canada focused on serving the specific needs of chefs who own and/or operate some...

PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference

Written by Customer Service on September 3, 2024. Posted in Public Companies.

PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today announced that Frank Bedu-Addo, PhD, President and Chief Executive Officer of PDS Biotech will present at the H.C. Wainwright 26th Annual Global Investment Conference taking place September 9-11, 2024 in New York City. Details of the presentation are as follows: H.C. Wainwright 26th Annual Global Investment ConferenceDate: Tuesday, September 10, 2024 Event: PresentationTime: 2:00-2:30 PM ET To register for the in-person event, please click here. The presentation will be available for on-demand viewing starting on September 10, 2024, at 2:00...

Enviri Corporation to participate in upcoming investor conferences

Written by Customer Service on September 3, 2024. Posted in Public Companies.

PHILADELPHIA, Sept. 03, 2024 (GLOBE NEWSWIRE) — Enviri Corporation (NYSE: NVRI), a global, market-leading provider of environmental solutions for industrial and specialty waste streams, today announced that Company management will be participating in the following upcoming investor conferences: Jefferies Industrial Conference (New York, NY)Wednesday, September 4, 2024 Lake Street: 2024 BIG8 Conference (New York, NY)Thursday, September 12, 2024 About Enviri Enviri is transforming the world to green, as a trusted global leader in providing a broad range of environmental services and related innovative solutions. The Company serves a diverse customer base by offering critical recycle and reuse solutions for their waste streams, enabling customers to address their most complex environmental challenges and to achieve their sustainability...

Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Written by Customer Service on September 3, 2024. Posted in Public Companies.

NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on Monday, September 9, 2024 at 1:30 pm ET. A live webcast of the presentation can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcast will be archived for a limited time following the presentation. About Protara Therapeutics, Inc. Protara is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead candidate, TARA-002, an investigational...

Gaming Analytics Platform Blitz Chooses Magnite as Preferred SSP to Streamline Programmatic Strategy

Written by Customer Service on September 3, 2024. Posted in Public Companies.

Centralizing all programmatic deals through Magnite provides advertisers with more efficient access to Blitz’s diverse audience NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — Blitz, a premier analytics platform offering real-time insights, stats, and improvement tools for gamers, has selected Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, as its preferred SSP. This builds on a successful partnership that has seen Blitz’s gross revenue grow triple-digit percent on Magnite’s DV+ SSP in the first half of 2024. Blitz is concentrating all programmatic deals through Magnite to offer advertisers easier access to the company’s omnichannel inventory including display and video. Blitz offers a dedicated activity-tracking platform used by millions of engaged gamers worldwide, including in the US, Canada, UK, Australia,...

Invesco Ltd: Form 8.3 – REA Group Ltd; Opening Position Disclosure

Written by Customer Service on September 3, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Invesco Ltd. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree REA Group Ltd (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior to...

Colliers to acquire leading Western Australian engineering firm

Written by Customer Service on September 3, 2024. Posted in Mergers And Acquisitions.

Acquisition expands geographic presence, scale and service capabilities TORONTO AND PERTH, Sept. 03, 2024 (GLOBE NEWSWIRE) — Global diversified professional services and investment management company, Colliers (NASDAQ, TSX: CIGI), announced today that Colliers Engineering & Design Australia (“Colliers Engineering”) has entered into a definitive agreement to acquire Pritchard Francis Consulting Pty Limited (“Pritchard Francis”), one of Western Australia’s leading multi-discipline engineering consulting firms. Pritchard Francis’ senior leadership team will continue to lead the business in Western Australia and become significant shareholders in the Colliers Engineering platform under the unique Colliers partnership model. The business will rebrand as “Colliers Engineering & Design” and fully integrate into Colliers’ rapidly...

Day: September 3, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice